2023-08-22 13:34:38 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited ( TEVA ) Q2 2023 Earnings Call Transcript
- Teva Q2 Earnings: Austedo And Anda Growth Impress, But Challenges Remain
- Teva Pharmaceutical Industries Limited 2023 Q2 - Results - Earnings Call Presentation
- Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story
- Teva settles DOJ price-fixing case for $225M, plus product divestiture
- Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement
- Teva CEO sees no value now in separating brands, generics businesses
- Teva estimates $200M impact from DOJ price fixing case
- Seeking Alpha’s Quant Rating on Teva Pharmaceutical
- Earnings data for Teva Pharmaceutical
For further details see:
BofA sees Teva paying $1.5B total to settle price-fixing litigation